99% Purity Semax In Endocrine System Nootropic Drugs
Détail rapide:
Nom du produit: |
Semax |
N ° CAS: |
80714-61-0 |
Pureté: |
sur 98% |
Formule moléculaire: |
C37H51N9O10S |
Apparence: |
poudre blanche |
Structure: |
Met-Glu-His-Phe-Pro-Gly-Pro |
Semax Description:
Semax is a drug produced and prescribed mostly in Russia and Ukraine for a broad range of conditions but predominantly for its purported nootropic, neuroprotective, and neurogenic/neurorestorative properties. It is aheptapeptide, synthetic analog of a fragment of adrenocorticotropic hormone (ACTH), ACTH (4-10), of the following structure: Met-Glu-His-Phe-Pro-Gly-Pro.
Semax is what’s called a synthetic heptapeptide, meaning that it’s a chain of 7 amino acids as a single molecule. Interestingly enough, the semax molecule mirrors a fragment of adrenocorticotropic hormone, which is released in the pituitary gland of humans in response to environmental stress.
It was originally developed in Moscow, Russia as a treatment mostly for neurological-related disorders, such as poor memory, depression, ADHD, and post-stroke treatment.
Semax is a new heptapeptide nootropic.
Semax was developed in 1982 by a research team from the Institute of Molecular Genetics at the Russian Academy of Sciences in Moscow.
It was initially pursued as a treatment for stroke victims suffering bran damage but was subsequently determined to promote significant cognitive enhancement in healthy individuals as well.
This nootropic stimulates the Central Nervous System and increases memory, focus, mental and physical performance, and analytical skills. It is regarded as much safer than other stimulants and does not cause negative side effects, Ritalin or Ephedrine